Mercer Global Advisors
RCUS icon

Mercer Global Advisors’s Arcus Biosciences RCUS Stock Holding History

Mercer Global Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.5K Buy
+1,865
New +$46.1K ﹤0.01% 4219

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mercer Global Advisors's RCUS Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 1,865 shares worth $57.5K. The stake represents ﹤0.01% of the portfolio and ranks #4219 among its holdings.

214 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Mercer Global Advisors held 1,865 shares of Arcus Biosciences worth $57.5K as of Q2 2026.
  • Arcus Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4219 holding.
  • 214 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.